Understanding How the Blood-Brain Barrier Facilitate Targeted Delivery of Drugs to the Brain
•
3 min read
Approximately 98% of small-molecule drugs fail to cross the blood-brain barrier (BBB), making central nervous system (CNS) diseases incredibly difficult to treat. Modern pharmacology is leveraging the very mechanisms of this protective barrier to facilitate targeted delivery of drugs to the brain, using advanced engineering to overcome its natural resistance.
